Corticotroph aggressive pituitary tumors and carcinomas frequently harbor ATRX mutations
O Casar-Borota, HB Boldt, BE Engström… - The Journal of …, 2021 - academic.oup.com
Abstract Context Aggressive pituitary tumors (APTs) are characterized by unusually rapid
growth and lack of response to standard treatment. About 1% to 2% develop metastases …
growth and lack of response to standard treatment. About 1% to 2% develop metastases …
The chromatin remodeler ATRX: role and mechanism in biology and cancer
Y Pang, X Chen, T Ji, M Cheng, R Wang, C Zhang… - Cancers, 2023 - mdpi.com
Simple Summary ATRX is one of the most frequently mutated tumor suppressor genes in
human cancers. ATRX protein is a chromatin remodeler and transcriptional regulator that is …
human cancers. ATRX protein is a chromatin remodeler and transcriptional regulator that is …
TERT promoter methylation is significantly associated with TERT upregulation and disease progression in pituitary adenomas
Y Miyake, J Adachi, T Suzuki, K Mishima, R Araki… - Journal of neuro …, 2019 - Springer
Purpose Alterations in the promoter of the telomerase reverse transcriptase (TERT) gene are
a major mechanism of upregulating telomerase, which plays a crucial role in tumor …
a major mechanism of upregulating telomerase, which plays a crucial role in tumor …
Pituitary adenoma in pediatric and adolescent populations
J Chen, RE Schmidt, S Dahiya - Journal of Neuropathology & …, 2019 - academic.oup.com
Pituitary adenomas are rare in children and adolescents and although mostly benign, they
can sometimes be challenging to manage due to their locally invasive nature. In this study …
can sometimes be challenging to manage due to their locally invasive nature. In this study …
In Japanese patients with papillary thyroid carcinoma, TERT promoter mutation is associated with poor prognosis, in contrast to BRAF V600E mutation
The prognostic value of BRAF V600E and TERT promoter mutation in papillary thyroid
carcinoma (PTC) is controversial. We examined alterations in BRAF V600E and TERT …
carcinoma (PTC) is controversial. We examined alterations in BRAF V600E and TERT …
ATRX, a guardian of chromatin
P Aguilera, AJ López-Contreras - Trends in Genetics, 2023 - cell.com
ATRX (alpha-thalassemia mental retardation X-linked) is one of the most frequently mutated
tumor suppressor genes in human cancers, especially in glioma, and recent findings …
tumor suppressor genes in human cancers, especially in glioma, and recent findings …
Association of TERT Promoter Mutation 1,295,228 C>T With BRAF V600E Mutation, Older Patient Age, and Distant Metastasis in Anaplastic Thyroid Cancer
Context: The aggressive role of TERT promoter mutations has been well established in
differentiated thyroid cancer but has not been established in anaplastic thyroid cancer …
differentiated thyroid cancer but has not been established in anaplastic thyroid cancer …
The activating TERT promoter mutation C228T is recurrent in subsets of adrenal tumors
T Liu, TC Brown, CC Juhlin… - Endocrine-related …, 2014 - erc.bioscientifica.com
The telomerase reverse transcriptase gene (TERT) encodes the reverse transcriptase
component of the telomerase complex, which is essential for telomere stabilization and cell …
component of the telomerase complex, which is essential for telomere stabilization and cell …
Mutant ATRX: uncovering a new therapeutic target for glioma
S Haase, MB Garcia-Fabiani, S Carney… - Expert opinion on …, 2018 - Taylor & Francis
Introduction: ATRX is a chromatin remodeling protein whose main function is the deposition
of the histone variant H3. 3. ATRX mutations are widely distributed in glioma, and correlate …
of the histone variant H3. 3. ATRX mutations are widely distributed in glioma, and correlate …
Cell Cycle Deregulation and TP53 and RAS Mutations Are Major Events in Poorly Differentiated and Undifferentiated Thyroid Carcinomas
JM Pita, IF Figueiredo, MM Moura… - The Journal of …, 2014 - academic.oup.com
Background: Anaplastic thyroid carcinomas (ATCs) are among the most lethal malignancies,
for which there is no effective treatment. Objective: In the present study, we aimed to …
for which there is no effective treatment. Objective: In the present study, we aimed to …